About N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline
N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline (PubChem CID 144651950) has the molecular formula C26H31FN4O3S
and a molecular weight of 498.62 g/mol. Its IUPAC name is N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline.
Molecular Properties
| Compound Name | N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline |
| PubChem CID | 144651950 |
| Molecular Formula | C26H31FN4O3S |
| Molecular Weight | 498.62 g/mol |
| Exact Mass | 498.21 |
| IUPAC Name | N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline |
| SMILES | [H]/N=C(\CC)C(C)(C)S(=O)(=O)C[C@H](C)c1cc(NC(=C2CC2)c2cnc(OCC#C)cn2)ccc1F |
| InChI | InChI=1S/C26H31FN4O3S/c1-6-12-34-24-15-29-22(14-30-24)25(18-8-9-18)31-19-10-11-21(27)20(13-19)17(3)16-35(32,33)26(4,5)23(28)7-2/h1,10-11,13-15,17,28,31H,7-9,12,16H2,2-5H3/b28-23+/t17-/m0/s1 |
| InChIKey | JYEMJHCHTHGXLX-ZKAUOXRGSA-N |
| XLogP | 4.97 |
| TPSA | 105.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 498.62 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Analyze N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline?
The IUPAC name of N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline (CID 144651950) is N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline.
What is the SMILES notation for N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline?
The canonical SMILES for N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline is [H]/N=C(\CC)C(C)(C)S(=O)(=O)C[C@H](C)c1cc(NC(=C2CC2)c2cnc(OCC#C)cn2)ccc1F.
What is the InChIKey of N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline?
The InChIKey is JYEMJHCHTHGXLX-ZKAUOXRGSA-N. The full InChI is InChI=1S/C26H31FN4O3S/c1-6-12-34-24-15-29-22(14-30-24)25(18-8-9-18)31-19-10-11-21(27)20(13-19)17(3)16-35(32,33)26(4,5)23(28)7-2/h1,10-11,13-15,17,28,31H,7-9,12,16H2,2-5H3/b28-23+/t17-/m0/s1.
What are the key properties of N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline?
N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline has a molecular weight of 498.62 g/mol, XLogP of 4.97, 11 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[cyclopropylidene-(5-prop-2-ynoxypyrazin-2-yl)methyl]-4-fluoro-3-[(2R)-1-(3-imino-2-methylpentan-2-yl)sulfonylpropan-2-yl]aniline is sourced from PubChem (CID 144651950), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).